Pediatric expert consensus on the application of intravenous immunoglobulin in children with hematological/neoplastic diseases.
- Collective Name:Pediatric Branch of Guangdong Medical Association;Editorial Department of Chinese Journal of Contemporary Pediatrics
- Publication Type:Journal Article
- MeSH:
Child;
China;
Consensus;
Hematologic Neoplasms/drug therapy*;
Hematopoietic Stem Cell Transplantation;
Humans;
Immunoglobulins, Intravenous/therapeutic use*
- From:
Chinese Journal of Contemporary Pediatrics
2021;23(4):319-327
- CountryChina
- Language:Chinese
-
Abstract:
Intravenous immunoglobulin (IVIG) has been widely used in chemotherapy for hematological malignancies, targeted therapy, and hematopoietic stem cell transplantation; however, there are still no available guidelines or consensus statements on the application of IVIG in pediatric hematological/neoplastic diseases at present in China and overseas. This consensus is developed based on the research advances in the application of IVIG in pediatric hematological/neoplastic diseases across the world and provides detailed recommendations for the clinical application of IVIG in pediatric hematological/neoplastic diseases and the prevention and treatment of related adverse reactions.